Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study

References

• BrometEAndradeLHHwangICross-national epidemiology of DSM-IV major depressive episodeBMC Med201199021791035
   PubMed Web of Science ®Google Scholar
• WittchenHUJacobiFRehmJThe size and burden of mental disorders and other disorders of the brain in Europe 2010Eur Neuropsychopharmacol201121965567921896369
   PubMed Web of Science ®Google Scholar
• KesslerRCBerglundPDemierONational Comorbidity Survey ReplicationThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
   PubMed Web of Science ®Google Scholar
• PalssonSPOstlingSSkoogIThe incidence of first-onset depression in a population followed from the age of 70 to 85Psychol Med20013171159116811681542
   PubMed Web of Science ®Google Scholar
• KruijshaarMEBarendregtJVosTde GraafRSpijkerJAndrewsGLifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall biasEur J Epidemiol200520110311115756910
   PubMed Web of Science ®Google Scholar
• PattenSBAccumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too lowBMC Psychiatry200991919422724
   PubMed Web of Science ®Google Scholar
• AndrewsGPoultonRSkoogILifetime risk of depression: restricted to a minority of waiting for most?Br J Psychiatry200518749549616319399
   PubMed Web of Science ®Google Scholar
• PattenSBWangJLWilliamsJVLavoratoDHBullochAEliasziwMProspective evaluation of the effect of major depression on working status in a population sampleCan J Psychiatry2009541284184520047723
   PubMed Web of Science ®Google Scholar
• LenzeEJSchulzRMartireLMThe course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health StudyJ Am Geriatr Soc200553456957515817000
   PubMed Web of Science ®Google Scholar
• MurrayCJLLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet19973499064149815049167458
   PubMed Web of Science ®Google Scholar
• OlesenJGustavssonASvenssonMWittchenHUJönssonBCDBE2010 study group; European Brain CouncilThe economic cost of brain disorders in EuropeEur J Neurol201219115516222175760
   PubMed Web of Science ®Google Scholar
• de BodinatCGuardiola-LemaitreBMocaërERenardPMuñozCMillanMJAgomelatine, the first melatonergic antidepressant: discovery, characterization and developmentNat Rev Drug Discov20109862864220577266
   PubMed Web of Science ®Google Scholar
• DemyttenaereKAgomelatine: a narrative reviewEur Neuropsychopharmacol201121Suppl 4S703S70921835598
   PubMed Web of Science ®Google Scholar
• Quera-SalvaMAHajakGPhilipPComparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patientsInt Clin Psychopharmacol201126525226221829106
   PubMed Web of Science ®Google Scholar
• KennedySHEmsleyRPlacebo-controlled trial of agomelatine in the treatment of major depressive disorderEur Neuropsychopharmacol20061629310016249073
   PubMed Web of Science ®Google Scholar
• OliéJPKasperSEfficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorderInt J Neuropsychopharmacol200710566167317477888
   PubMed Web of Science ®Google Scholar
• LemoinePGuilleminaultCAlvarezEImprovement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxineJ Clin Psychiatry200768111723173218052566
   PubMed Web of Science ®Google Scholar
• KasperSHajakGWulffKEfficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertralineJ Clin Psychiatry201071210912020193645
   PubMed Web of Science ®Google Scholar
• HaleACorralRMMencacciCRuizJSSeveroCAGentilVSuperior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind studyInt Clin Psychopharmacol201025630531420856123
   PubMed Web of Science ®Google Scholar
• LauxGVIVALDI Study GroupThe antidepressant agomelatine in daily practice: results of the non-interventional study VIVALDIPharmacopsychiatry201245728429122592503
   PubMed Web of Science ®Google Scholar
• SeemüllerFRiedelMObermeierMOutcomes of 1014 naturalistically treated in patients with major depressive episodeEur Neuropsychopharmacol201020534635520097046
   PubMed Web of Science ®Google Scholar
• TrivediMHRushAJNierenbergAASTAR*D Study TeamEvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practiceAm J Psychiatry20061631284016390886
   PubMed Web of Science ®Google Scholar
• KatzMMBowdenCLFrazerARethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioural elementsJ Affect Disord20101201–3162319735945
   PubMed Web of Science ®Google Scholar
• Machado-VieiraRSalvadoreGLuckenbaughDAManjiHKZarateCAJrRapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorderJ Clin Psychiatry200869694695818435563
   PubMed Web of Science ®Google Scholar
• ChangTFavaMThe future of psychopharmacology of depressionJ Clin Psychiatry201071897197520797377
   PubMed Web of Science ®Google Scholar
• PerlisRHOstacherMJGoldbergJFTransition to mania during treatment of bipolar depressionNeuropsychopharmacology201035132545255220827274
   PubMed Web of Science ®Google Scholar
• GoodwinGMEmsleyRRembrySRouillonFAgomelatine Study GroupAgomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trialJ Clin Psychiatry20097081128113719689920
   PubMed Web of Science ®Google Scholar
• MontgomerySAKennedySHBurrowsGDLejoyeuxMHindmarchIAbsence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation studyInt Clin Psychopharmacol200419527128015289700
   PubMed Web of Science ®Google Scholar